Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arvinas (ARVN) Research & Development (2017 - 2025)

Historic Research & Development for Arvinas (ARVN) over the last 9 years, with Q3 2025 value amounting to $64.7 million.

  • Arvinas' Research & Development fell 2554.66% to $64.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $307.4 million, marking a year-over-year decrease of 1463.48%. This contributed to the annual value of $348.2 million for FY2024, which is 829.6% down from last year.
  • As of Q3 2025, Arvinas' Research & Development stood at $64.7 million, which was down 2554.66% from $68.6 million recorded in Q2 2025.
  • In the past 5 years, Arvinas' Research & Development registered a high of $103.4 million during Q2 2023, and its lowest value of $34.9 million during Q1 2021.
  • Its 5-year average for Research & Development is $76.2 million, with a median of $83.3 million in 2024.
  • In the last 5 years, Arvinas' Research & Development surged by 9088.67% in 2022 and then tumbled by 2678.76% in 2025.
  • Over the past 5 years, Arvinas' Research & Development (Quarter) stood at $61.9 million in 2021, then surged by 58.8% to $98.3 million in 2022, then decreased by 3.15% to $95.2 million in 2023, then fell by 12.5% to $83.3 million in 2024, then dropped by 22.33% to $64.7 million in 2025.
  • Its Research & Development stands at $64.7 million for Q3 2025, versus $68.6 million for Q2 2025 and $90.8 million for Q1 2025.